Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Insulet raises $35.5mm in fourth round

Executive Summary

Insulet (disposable insulin delivery system) raised $35.5mm in its Series D private financing, which was led by Alta Partners and joined by other new investors MedVenture Associates, TIAA-CREF, Piper Jaffray ventures, and Diamond Capital Management. Return backers included Pequot Ventures, Versant Ventures, Schroder Ventures Life Sciences, Oakwood Medical Investors and founding investor Prism Venture Partners.
Deal Industry
  • Pharmaceuticals
  • Pharmaceuticals
    • Drug Delivery
      • Macromolecule
  • Medical Devices
    • Infusion Therapy Equipment and Supplies
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies